Managing Stable COPD in 2009: Incorporating Results from Recent Clinical Studies into a Goal-Directed Approach for Clinicians

References

• . Celli BR. Update on the management of COPD. Chest. 2008; 133(6):1451–1462
   PubMed Web of Science ®Google Scholar
• . Gross N, Levin D. Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease. Am J Med. 2008;121( 7 suppl):S13–S24
   PubMed Web of Science ®Google Scholar
• . Rabe KF, Hurd S, Anzueto A, ; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555
   PubMed Web of Science ®Google Scholar
• . Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. November 2008. www.goldcopd.org. Accessed December 1, 2008.
   Google Scholar
• . Han MK, Kim MG, Mardon R, . Spirometry utilization for COPD: how do we measure up? Chest. 2007;132(2):403–409
   PubMed Web of Science ®Google Scholar
• . Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest. 1993;104(1):254–258
   PubMed Web of Science ®Google Scholar
• . Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119(6):1691–1695
   PubMed Web of Science ®Google Scholar
• . Lee TA, Bartle B, Weiss KB, . Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129(6):1509–1515
   PubMed Web of Science ®Google Scholar
• . Dales RE, Vandemheen KL, Clinch J, Aaron SD. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest. 2005;128(4):2443–2447
   PubMed Web of Science ®Google Scholar
• . Celli BR, Cote CG, Marin JM, . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012
   PubMed Web of Science ®Google Scholar
• . Wilt TJ, Niewoehner D, MacDonald R, . Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Ann Intern Med. 2007;147(9):639–653
   PubMed Web of Science ®Google Scholar
• . Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–977
   PubMed Web of Science ®Google Scholar
• . Oga T, Nishimura K, Tsukino M, . Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest. 2005;128(1):62–69
   PubMed Web of Science ®Google Scholar
• . Cooper CB, Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease-part 4: understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121( 7 suppl): S33–S45
   PubMed Web of Science ®Google Scholar
• . Ries AL, Make BJ, Reilly JJ, . Pulmonary rehabilitation in emphysema. Proc Am Thorac Soc. 2008;5(4):524–529
   PubMedGoogle Scholar
• . Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119(10 suppl 1):21–31
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD. 2007;4(3):225–236
   PubMedGoogle Scholar
• . Vincken W, van Noord JA, Greefhorst AP, ; Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Resp J. 2002;19(2):209–216
   PubMed Web of Science ®Google Scholar
• . Calverley PM, Boonsawat W, Cseke Z, . Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J. 2003;22(6):912–919
   PubMed Web of Science ®Google Scholar
• . Barr RG, Bourbeau J, Camargo CA, Ram FS. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;2:CD002876
   Google Scholar
• . O'Donnell DE, Fluge T, Gerken F, . Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–840
   PubMed Web of Science ®Google Scholar
• . Maltais F, Hamilton A, Marciniuk D, . Improvements in symptom limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128:1168–1178
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Voduc N, Fitzpatrick M, . Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):86–94
   PubMed Web of Science ®Google Scholar
• . O'Donnell DE, Sciurba F, Celli B, . Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest. 2006;130(3):647–656
   PubMed Web of Science ®Google Scholar
• . Tashkin DP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125(1):249–259
   PubMed Web of Science ®Google Scholar
• . van Noord JA, Aumann JL, Janssens E, . Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J. 2005;26(2):214–222
   PubMed Web of Science ®Google Scholar
• . Casaburi R, Kukafka D, Cooper CB, . Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127(3):809–817
   PubMed Web of Science ®Google Scholar
• . National Heart, Lung, and Blood Institute Fact Sheet. http://www.nhlbi.nih.gov/health/public/lung/other/copd_dci.htm. Accessed December 1, 2008.
   Google Scholar
• . Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s
   PubMedGoogle Scholar
• . Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD. 2006;3:75–81
   PubMedGoogle Scholar
• . Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130(5):397–403
   PubMed Web of Science ®Google Scholar
• . Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290(17):2301–2312
   PubMed Web of Science ®Google Scholar
• . Niewoehner DE, Rice K, Cote C, . Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005;143(5):317–326
   PubMed Web of Science ®Google Scholar
• . Calverley PM, Anderson JA, Celli B, ; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789
   PubMed Web of Science ®Google Scholar
• . Kardos P, Wencker M, Glaab T, . Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(2):144–149
   PubMed Web of Science ®Google Scholar
• . Burge PS, Calverley PM, Jones PW, . Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320(7245):1297–1303
   PubMed Web of Science ®Google Scholar
• . Cazzola M, Dahl R. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD. Chest. 2004;126(1):220–237
   PubMed Web of Science ®Google Scholar
• . Szafranski W, Cukier A, Ramirez A, . Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Resp J. 2003;21(1):74–81
   PubMed Web of Science ®Google Scholar
• . Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations. Respiratory Medicine. 2008;102(8):1099–1108
   PubMed Web of Science ®Google Scholar
• . Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177(1):19–26
   PubMed Web of Science ®Google Scholar
• . Aaron SD, Vandemheen KL, Fergusson D, ; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2007;146(8):545–555
   PubMed Web of Science ®Google Scholar
• . Peytremann-Bridevaux I, Staeger P, Bridevaux PO, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med. 2008;121(5):433–443.e4
   PubMed Web of Science ®Google Scholar
• . Rice KL, Dewan N, Bloomfield HE, . Case/self management for COPD: a randomized controlled trial. Am J Resp Crit Care Med. 2008;177:A868
   Web of Science ®Google Scholar
• . Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980;93:391–398
   PubMed Web of Science ®Google Scholar
• . Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681–686
   PubMedGoogle Scholar
• . Celli BR, Thomas NE, Anderson JA, . Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338
   PubMed Web of Science ®Google Scholar
• . Tashkin DP, Celli B, Senn S, ; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554
   PubMed Web of Science ®Google Scholar
• . Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med. 2008;149(6):380–390
   PubMed Web of Science ®Google Scholar
• . Singh S, Loke YK, Furberg CD, . Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300(12):1439–1450
   PubMed Web of Science ®Google Scholar
• . Gianakos D, Kaczynski R. Are your COPD patients benefiting from best practices? J Fam Pract. 2008;57(8):532–536
   PubMed Web of Science ®Google Scholar